Screw‐retained ceramic‐veneered/monolithic zirconia partial implant‐supported fixed dental prostheses: A 5 to 10‐year retrospective study on survival and complications
Yifan Zhang,
Jia Luo,
Ping Di
et al.
Abstract:PurposeTo assess the clinical performance of screw‐retained, ceramic‐veneered, monolithic zirconia partial implant‐supported fixed dental prostheses (ISFDP) over 5–10 years and to evaluate implant‐ and prosthesis‐related factors influencing treatment failure and complications.Materials and methodsPartially edentulous patients treated with screw‐retained all‐ceramic ISFDPs with 2–4 prosthetic units with a documented follow‐up of ≥5 years after implant loading were included in this retrospective study. The outco… Show more
“…When the fragile‐veneered area, such as the marginal ridge and cusp, are subjected to increased bite force (often occurring on the position of the first molar), chipping is more likely to occur with greater frequency and ease. Considering aesthetics and function, it is suggested that partial veneers retaining the functional occlusal area as zirconia may be a better option than conventional full‐coverage ones (Zhang et al, 2023).…”
ObjectivesTo compare the survival and complication rates of posterior screw‐retained monolithic lithium disilicate (LS2)/veneered zirconia (ZrO2) single implant crowns (SICs), as well as analyze the occlusal changes observed during a 3‐year follow‐up period.Materials and MethodsThirty‐three patients were included and randomly divided into two groups. The test group consisted of 17 patients who received monolithic‐LS2–SIC, while the control group consisted of 16 patients who received veneered‐ZrO2‐SIC. Implant/prosthesis survival rates, technical complications, peri‐implant soft tissue conditions, and quantitative occlusal changes of SIC (obtained by the intra‐oral scanner and analyzed in reverse software Geomagic Control 2015) were assessed at 1‐ and 3‐year follow‐ups. Bone loss and Functional Implant Prosthodontic Score (FIPS) were evaluated at a 3‐year follow‐up.ResultsAfter a 3‐year follow‐up period, one patient dropped out of the follow‐up. No implant loss was observed. One crown was fractured, resulting in prosthesis survival rates of 93.75% for the monolithic group and 100% for the veneered group. A technical complication rate of 25% (4/16) was observed in the veneered group (p = .333). No significant differences in the marginal bone loss were observed at the 3‐year follow‐up (0.00 (−0.22, 0.17) mm versus 0.00 (−0.12, 0.12) mm, p = .956). The total FIPS scores for the test group were 9.0 (9.0, 9.0), while the control group received scores of 9.0 (8.0, 10.0) (p = .953). The changes in mean occlusal clearance were 0.022 ± 0.083 mm for the test and 0.034 ± 0.077 mm for the control group (at 3 years, p = .497). The changes in occlusal contact area were 1.075 ± 2.575 mm2 for the test and 1.676 ± 2.551 mm2 for the control group (at 3 years, p = .873).ConclusionAfter a 3‐year follow‐up, screw‐retained monolithic LS2 and veneered ZrO2 SIC demonstrated similar survival rates. The occlusal performance of implant prostheses needs to be closely examined during follow‐up, and appropriate occlusal adjustments need to be considered.
“…When the fragile‐veneered area, such as the marginal ridge and cusp, are subjected to increased bite force (often occurring on the position of the first molar), chipping is more likely to occur with greater frequency and ease. Considering aesthetics and function, it is suggested that partial veneers retaining the functional occlusal area as zirconia may be a better option than conventional full‐coverage ones (Zhang et al, 2023).…”
ObjectivesTo compare the survival and complication rates of posterior screw‐retained monolithic lithium disilicate (LS2)/veneered zirconia (ZrO2) single implant crowns (SICs), as well as analyze the occlusal changes observed during a 3‐year follow‐up period.Materials and MethodsThirty‐three patients were included and randomly divided into two groups. The test group consisted of 17 patients who received monolithic‐LS2–SIC, while the control group consisted of 16 patients who received veneered‐ZrO2‐SIC. Implant/prosthesis survival rates, technical complications, peri‐implant soft tissue conditions, and quantitative occlusal changes of SIC (obtained by the intra‐oral scanner and analyzed in reverse software Geomagic Control 2015) were assessed at 1‐ and 3‐year follow‐ups. Bone loss and Functional Implant Prosthodontic Score (FIPS) were evaluated at a 3‐year follow‐up.ResultsAfter a 3‐year follow‐up period, one patient dropped out of the follow‐up. No implant loss was observed. One crown was fractured, resulting in prosthesis survival rates of 93.75% for the monolithic group and 100% for the veneered group. A technical complication rate of 25% (4/16) was observed in the veneered group (p = .333). No significant differences in the marginal bone loss were observed at the 3‐year follow‐up (0.00 (−0.22, 0.17) mm versus 0.00 (−0.12, 0.12) mm, p = .956). The total FIPS scores for the test group were 9.0 (9.0, 9.0), while the control group received scores of 9.0 (8.0, 10.0) (p = .953). The changes in mean occlusal clearance were 0.022 ± 0.083 mm for the test and 0.034 ± 0.077 mm for the control group (at 3 years, p = .497). The changes in occlusal contact area were 1.075 ± 2.575 mm2 for the test and 1.676 ± 2.551 mm2 for the control group (at 3 years, p = .873).ConclusionAfter a 3‐year follow‐up, screw‐retained monolithic LS2 and veneered ZrO2 SIC demonstrated similar survival rates. The occlusal performance of implant prostheses needs to be closely examined during follow‐up, and appropriate occlusal adjustments need to be considered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.